| Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma MA Qazi, P Vora, C Venugopal, SS Sidhu, J Moffat, C Swanton, SK Singh Annals of Oncology 28 (7), 1448-1456, 2017 | 362 | 2017 |
| Childhood cerebellar tumours mirror conserved fetal transcriptional programs MC Vladoiu, I El-Hamamy, LK Donovan, H Farooq, BL Holgado, ... Nature 572 (7767), 67-73, 2019 | 356 | 2019 |
| The rational development of CD133-targeting immunotherapies for glioblastoma P Vora, C Venugopal, SK Salim, N Tatari, D Bakhshinyan, M Singh, ... Cell Stem Cell 26 (6), 832-844. e6, 2020 | 134 | 2020 |
| Pyrvinium targets CD133 in human glioblastoma brain tumor–initiating cells C Venugopal, R Hallett, P Vora, B Manoranjan, S Mahendram, MA Qazi, ... Clinical Cancer Research 21 (23), 5324-5337, 2015 | 65 | 2015 |
| STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation M Singh, N Garg, C Venugopal, R Hallett, T Tokar, N McFarlane, ... Oncotarget 6 (29), 27461, 2015 | 60 | 2015 |
| Cotargeting ephrin receptor tyrosine kinases A2 and A3 in cancer stem cells reduces growth of recurrent glioblastoma MA Qazi, P Vora, C Venugopal, J Adams, M Singh, A Hu, M Gorelik, ... Cancer Research 78 (17), 5023-5037, 2018 | 46 | 2018 |
| Therapeutic targeting of the premetastatic stage in human lung-to-brain metastasis M Singh, C Venugopal, T Tokar, N McFarlane, MK Subapanditha, M Qazi, ... Cancer research 78 (17), 5124-5134, 2018 | 42 | 2018 |
| RNAi screen identifies essential regulators of human brain metastasis-initiating cells M Singh, C Venugopal, T Tokar, KR Brown, N McFarlane, D Bakhshinyan, ... Acta Neuropathologica 134, 923-940, 2017 | 33 | 2017 |
| BMI1 is a therapeutic target in recurrent medulloblastoma D Bakhshinyan, C Venugopal, AA Adile, N Garg, B Manoranjan, R Hallett, ... Oncogene 38 (10), 1702-1716, 2019 | 30 | 2019 |
| Introduction to cancer stem cells: past, present, and future D Bakhshinyan, AA Adile, MA Qazi, M Singh, MM Kameda-Smith, N Yelle, ... Cancer Stem Cells: Methods and Protocols, 1-16, 2018 | 26 | 2018 |
| A novel stem cell culture model of recurrent glioblastoma MA Qazi, P Vora, C Venugopal, N McFarlane, MK Subapanditha, ... Journal of neuro-oncology 126, 57-67, 2016 | 25 | 2016 |
| Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells P Vora, M Seyfrid, C Venugopal, MA Qazi, S Salim, R Isserlin, ... Journal of Neuro-Oncology 143, 417-428, 2019 | 16 | 2019 |
| Deciphering brain tumor heterogeneity, one cell at a time MA Qazi, D Bakhshinyan, SK Singh Nature Medicine 25 (10), 1474-1476, 2019 | 14 | 2019 |
| Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence D Bakhshinyan, AA Adile, J Liu, WD Gwynne, Y Suk, S Custers, I Burns, ... Science Advances 7 (50), eabi5568, 2021 | 11 | 2021 |
| Generation of murine xenograft models of brain tumors from primary human tissue for in vivo analysis of the brain tumor-initiating cell M Qazi, A Mann, R van Ommeren, C Venugopal, N McFarlane, P Vora, ... Stem Cells and Tissue Repair: Methods and Protocols, 37-49, 2014 | 10 | 2014 |
| EPH profiling of BTIC populations in glioblastoma multiforme using CyTOF AX Hu, JJ Adams, P Vora, M Qazi, SK Singh, J Moffat, SS Sidhu Brain Tumor Stem Cells: Methods and Protocols, 155-168, 2019 | 9 | 2019 |
| PD-L1 expression in breast cancer brain metastases R Chehade, MA Qazi, M Ennis, A Sahgal, S Das, S Nofech-Mozes, ... Neuro-Oncology Advances 4 (1), vdac154, 2022 | 5 | 2022 |
| Identification of five important genes to predict glioblastoma subtypes Y Tang, MA Qazi, KR Brown, N Mikolajewicz, J Moffat, SK Singh, ... Neuro-Oncology Advances 3 (1), vdab144, 2021 | 5 | 2021 |
| Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma MA Qazi, SK Salim, KR Brown, N Mikolajewicz, N Savage, H Han, ... Cell Reports 40 (13), 2022 | 4 | 2022 |
| Abstract B079: The efficacy of CD133 BiTEs and CAR-T cells in preclinical model of recurrent glioblastoma P Vora, C Chokshi, M Qazi, C Venugopal, S Mahendram, M Singh, ... Cancer Immunology Research 4 (11_Supplement), B079-B079, 2016 | 3 | 2016 |
